The use of national reimbursement reports to support formulary decisions of the hospital’s Drug and Therapeutics Committee: a comparative analysis
Crossref DOI link: https://doi.org/10.1007/s11096-022-01384-w
Published Online: 2022-02-24
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Claus, Barbara
Commeyne, Sabrina
Van de Casteele, Marc
Rottey, Sylvie
Text and Data Mining valid from 2022-02-24
Version of Record valid from 2022-02-24
Article History
Received: 15 October 2021
Accepted: 3 February 2022
First Online: 24 February 2022
Conflicts of interest
: No conflict of interest to declare.